Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Receivables (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Change in Receivables for 9 consecutive years, with $11.6 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 194.61% to $11.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.2 million through Dec 2025, up 908.19% year-over-year, with the annual reading at $26.2 million for FY2025, 908.19% up from the prior year.
  • Change in Receivables hit $11.6 million in Q4 2025 for Inspire Medical Systems, up from -$29.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $44.6 million in Q2 2025 to a low of -$29.7 million in Q3 2025.
  • Historically, Change in Receivables has averaged $4.8 million across 5 years, with a median of $5.2 million in 2022.
  • Biggest five-year swings in Change in Receivables: soared 500.37% in 2021 and later crashed 1173.47% in 2024.
  • Year by year, Change in Receivables stood at $7.5 million in 2021, then surged by 68.27% to $12.6 million in 2022, then skyrocketed by 47.6% to $18.6 million in 2023, then crashed by 78.8% to $3.9 million in 2024, then soared by 194.61% to $11.6 million in 2025.
  • Business Quant data shows Change in Receivables for INSP at $11.6 million in Q4 2025, -$29.7 million in Q3 2025, and $44.6 million in Q2 2025.